Professor Richard Epstein
Vice President for Healthcare Outcomes Policy and
Oncology and Molecular Radiation Sciences
University of Sydney
Professor Epstein is a Senior Consultant Medical Oncologist who treats cancer patients in the Department of Oncology at The Kinghorn Cancer Centre. He has key therapeutic interests in breast cancer, prostate and kidney cancers, melanoma and skin cancers and eye tumours, transplant-related tumours, and neuroendocrine tumours.
In addition, he heads the Clinical Trials Centre, which prioritises studies of ‘smart’ drugs that target specific biological molecules important for driving cancer growth. Professor Epstein also heads the Genome Evolution research group in The Kinghorn Cancer Centre with interests in cancer causation and novel therapeutic strategies; one of the lab’s current theme projects involves using genetic engineering to make ‘cancer-resistant’ genes.